Katrina L. Creech

2.4k total citations
23 papers, 1.4k citations indexed

About

Katrina L. Creech is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Katrina L. Creech has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Katrina L. Creech's work include Drug Transport and Resistance Mechanisms (6 papers), Hepatitis C virus research (5 papers) and Estrogen and related hormone effects (4 papers). Katrina L. Creech is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Hepatitis C virus research (5 papers) and Estrogen and related hormone effects (4 papers). Katrina L. Creech collaborates with scholars based in United States, United Kingdom and Australia. Katrina L. Creech's co-authors include Derek J. Parks, Timothy M. Willson, Stacey A. Jones, Linda B. Moore, Kelli D. Plunket, Joan G. Wilson, Patrick Maloney, Curt D. Haffner, Gyan Chandra and Adam M. Fivush and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Katrina L. Creech

23 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrina L. Creech United States 16 651 429 286 279 213 23 1.4k
Astrid Kaiser Germany 21 324 0.5× 729 1.7× 70 0.2× 171 0.6× 136 0.6× 63 1.3k
Kelli Bramlett United States 22 561 0.9× 903 2.1× 463 1.6× 107 0.4× 185 0.9× 36 1.6k
Wenwei Lin United States 23 348 0.5× 645 1.5× 82 0.3× 101 0.4× 57 0.3× 61 1.4k
Anders Wetterholm Sweden 23 310 0.5× 660 1.5× 118 0.4× 179 0.6× 113 0.5× 49 1.7k
René Hennig Germany 23 254 0.4× 951 2.2× 230 0.8× 237 0.8× 143 0.7× 60 1.7k
Wanda Cromlish Canada 25 202 0.3× 925 2.2× 142 0.5× 392 1.4× 102 0.5× 34 2.1k
Paul S. Jones United Kingdom 20 230 0.4× 611 1.4× 31 0.1× 158 0.6× 87 0.4× 44 1.2k
Rubén D. Garcia-Ordoñez United States 16 169 0.3× 580 1.4× 122 0.4× 80 0.3× 55 0.3× 25 1.2k
Ke‐He Ruan United States 23 110 0.2× 733 1.7× 98 0.3× 100 0.4× 48 0.2× 79 1.4k
Richard Hajdu United States 18 220 0.3× 1.9k 4.4× 86 0.3× 337 1.2× 209 1.0× 24 2.8k

Countries citing papers authored by Katrina L. Creech

Since Specialization
Citations

This map shows the geographic impact of Katrina L. Creech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina L. Creech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina L. Creech more than expected).

Fields of papers citing papers by Katrina L. Creech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina L. Creech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina L. Creech. The network helps show where Katrina L. Creech may publish in the future.

Co-authorship network of co-authors of Katrina L. Creech

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina L. Creech. A scholar is included among the top collaborators of Katrina L. Creech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina L. Creech. Katrina L. Creech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Steven G., Katrina L. Creech, David J. Rickard, et al.. (2020). 595 Differential ligand binding distinguishes therapeutic from pathologic Aryl Hydrocarbon Receptor (AhR) modulating agents: Implications for inflammatory skin disease. Journal of Investigative Dermatology. 140(7). S81–S81. 9 indexed citations
2.
Chong, Pek Y., J. Brad Shotwell, John F. Miller, et al.. (2019). Design of N -Benzoxaborole Benzofuran GSK8175—Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor. Journal of Medicinal Chemistry. 62(7). 3254–3267. 45 indexed citations
3.
Zhang, Cunyu, Katrina L. Creech, William J. Zuercher, & Timothy M. Willson. (2019). Gram-scale synthesis of FICZ, a photoreactive endogenous ligand of the aryl hydrocarbon receptor. Scientific Reports. 9(1). 9982–9982. 11 indexed citations
4.
Tai, Vincent W.‐F., Dulce Garrido, Daniel J. Price, et al.. (2014). Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein. Bioorganic & Medicinal Chemistry Letters. 24(10). 2288–2294. 21 indexed citations
5.
Smalley, Terrence L., Sharon Boggs, Justin A. Caravella, et al.. (2014). Novel heterocyclic scaffolds of GW4064 as farnesoid X receptor agonists. Bioorganic & Medicinal Chemistry Letters. 25(2). 280–284. 15 indexed citations
6.
Voitenleitner, Christian, Renae M. Crosby, Katja Remlinger, et al.. (2013). In Vitro Characterization of GSK2485852, a Novel Hepatitis C Virus Polymerase Inhibitor. Antimicrobial Agents and Chemotherapy. 57(11). 5216–5224. 10 indexed citations
7.
Shotwell, J. Brad, Scott H. Dickerson, Octerloney B. McDonald, et al.. (2013). Discovery of Selective Small Molecule Type III Phosphatidylinositol 4-Kinase Alpha (PI4KIIIα) Inhibitors as Anti Hepatitis C (HCV) Agents. Journal of Medicinal Chemistry. 57(5). 2091–2106. 56 indexed citations
8.
Caravella, Justin A., Lihong Chen, Katrina L. Creech, et al.. (2011). Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene. Bioorganic & Medicinal Chemistry Letters. 21(20). 6154–6160. 28 indexed citations
9.
Bechtel, Jill, Renae M. Crosby, Stephanie Van Horn, et al.. (2011). 764 IN VITRO PROFILING OF GSK2336805, A POTENT AND SELECTIVE INHIBITOR OF HCV NS5A. Journal of Hepatology. 54. S307–S308. 7 indexed citations
10.
Bass, Jonathan Y., Justin A. Caravella, Lihong Chen, et al.. (2010). Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene. Bioorganic & Medicinal Chemistry Letters. 21(4). 1206–1213. 53 indexed citations
11.
Bass, Jonathan Y., Richard D. Caldwell, Justin A. Caravella, et al.. (2009). Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064. Bioorganic & Medicinal Chemistry Letters. 19(11). 2969–2973. 45 indexed citations
12.
Bass, Jonathan Y., Richard D. Caldwell, Justin A. Caravella, et al.. (2009). FXR agonist activity of conformationally constrained analogs of GW 4064. Bioorganic & Medicinal Chemistry Letters. 19(16). 4733–4739. 56 indexed citations
13.
Bass, Jonathan Y., Richard D. Caldwell, Justin A. Caravella, et al.. (2008). Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064. Bioorganic & Medicinal Chemistry Letters. 18(15). 4339–4343. 118 indexed citations
14.
Allen, Scott H., Brian A. Johns, Kristjan S. Gudmundsson, et al.. (2005). Synthesis of C-6 substituted pyrazolo[1,5-a]pyridines with potent activity against herpesviruses. Bioorganic & Medicinal Chemistry. 14(4). 944–954. 38 indexed citations
15.
Gudmundsson, Kristjan S., Brian A. Johns, Zhicheng Wang, et al.. (2005). Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses. Bioorganic & Medicinal Chemistry. 13(18). 5346–5361. 48 indexed citations
16.
Johns, Brian A., Kristjan S. Gudmundsson, Elizabeth M. Turner, et al.. (2005). Pyrazolopyridine antiherpetics: SAR of C2′ and C7 amine substituents. Bioorganic & Medicinal Chemistry. 13(7). 2397–2411. 50 indexed citations
17.
Chan, Joseph H., George A. Freeman, Jeffrey H. Tidwell, et al.. (2004). Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1. Journal of Medicinal Chemistry. 47(5). 1175–1182. 52 indexed citations
18.
Ding, Xunshan, et al.. (2004). Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X Receptor. Journal of Pharmacology and Experimental Therapeutics. 310(2). 528–535. 87 indexed citations
19.
Blednov, Yuri A., et al.. (2003). GABAA Receptor α1 and β2 Subunit Null Mutant Mice: Behavioral Responses to Ethanol. Journal of Pharmacology and Experimental Therapeutics. 305(3). 854–863. 84 indexed citations
20.
Maloney, Patrick, Derek J. Parks, Curt D. Haffner, et al.. (2000). Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR. Journal of Medicinal Chemistry. 43(16). 2971–2974. 464 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Astrid Kaiser Breakdown of academic impact, for papers by Kelli Bramlett Breakdown of academic impact, for papers by Wenwei Lin Breakdown of academic impact, for papers by Anders Wetterholm Breakdown of academic impact, for papers by René Hennig Breakdown of academic impact, for papers by Wanda Cromlish Breakdown of academic impact, for papers by Paul S. Jones Breakdown of academic impact, for papers by Rubén D. Garcia-Ordoñez Breakdown of academic impact, for papers by Ke‐He Ruan Breakdown of academic impact, for papers by Richard Hajdu
Rankless by CCL
2026